SkinHealth Systems Inc.

As of June 30, 2026, SkinHealth Systems Inc. carries a market capitalization of 90.10M, placing it among publicly traded companies globally. Its enterprise value stands at 251.06M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

SkinHealth Systems Inc.'s next confirmed earnings release is scheduled for November 10, 2026.

As of June 30, 2026, SkinHealth Systems Inc. has 6.51M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.31, and the price-to-book ratio stands at 1.62.

As of June 30, 2026, SkinHealth Systems Inc. trades at an EV/EBITDA multiple of 12.50 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.87 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 251.06M versus a market cap of 90.10M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, SkinHealth Systems Inc. maintains a current ratio of 1.76, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 660.53, indicating elevated leverage, while an interest coverage ratio of 0.79 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. posted a negative return on equity (ROE) of -43.89, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.72, reflecting losses generated across the asset base. The company generates approximately 444,855.83 in revenue per employee across its workforce of 652.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.84 indicates how many times SkinHealth Systems Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. recorded 4.71M in income tax expense. The company reported a pretax loss of -23.73M and -28.43M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, SkinHealth Systems Inc.'s stock has declined approximately 58.29% over the past 52 weeks. The 50-day moving average sits at 12.74, while the 200-day moving average is 17.31.

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. generated 290.05M in revenue and converted that into -28.43M in net income, yielding earnings per share of -4.41. EBITDA reached 20.08M, while operating income came in at -4.31M.

As of June 30, 2026, SkinHealth Systems Inc. holds 206.07M in cash and equivalents against 367.04M in total debt, resulting in a net debt position of 139.14M. Total book value stands at 55.57M, with working capital of 127.04M providing operational flexibility.

SkinHealth Systems Inc. produced 21.96M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.32M in capital expenditures, free cash flow totaled 16.64M - equivalent to 2.60 per share.

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. posted a gross margin of 66.35, reflecting its pricing power and cost economics. The operating margin of -1.49 and net profit margin of -9.80 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 18.65, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 24.91, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to SkinHealth Systems Inc. shareholders.

SkinHealth Systems Inc.'s most recent stock split took place on October 14, 2026 with a 20:1 split ratio.

As of June 30, 2026, SkinHealth Systems Inc. has an Altman Z-Score of -0.81, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.